Kim Bought a Skincare Business Already Known Abroad

When Seunghwan Kim announced Amorepacific's additional COSRX share purchase on 31 October 2023, the products already had an audience well beyond Korea. COSRX had entered Amazon in 2018. Its Advanced Snail range was reaching shoppers who encountered skincare through online recommendations and product searches, giving the larger company access to a business that had learned to speak directly to those customers.

The target reported first-half sales of KRW 190.2 billion and operating profit of KRW 71.7 billion in 2023, with more than 90% of sales overseas. For Kim, its appeal lay in differentiated products and an understanding of digital channels. He proposed combining those strengths with Amorepacific's management experience. The acquisition joined two ways of building a beauty company: a large research-led organisation and a younger brand whose customers were already dispersed internationally. The relationship had started with an investment in 2021. The partners subsequently developed The Vitamin C 23 Serum and The Retinol 0.1 Cream together. Those products made the proposed combination tangible before the larger purchase: laboratory and development capabilities could sit behind a range that retained its own name, packaging and customer conversation.

Source: Amorepacific · Original COSRX acquisition announcement, 31 October 2023

The Sellers Stayed Involved for a Longer Journey

Amorepacific exercised its option over further COSRX shares in 2023. The first transaction completed on 30 April 2024, when it acquired 240,000 shares for about KRW 608 billion. A further 48,000 shares were scheduled to follow. By then the buyer could begin working with a controlled subsidiary while the sellers still had an interest in its future.

In April 2025, the parties extended the second acquisition's scheduled closing from 30 April that year to 30 April 2030, allowing an earlier transfer. The roughly KRW 147.1 billion second payment remained adjustable. The revised arrangement took account of the business's performance and factors including dividends and net income during the extension.

This stretched the relationship beyond the original timetable. Product development, distribution and the treatment of an internationally recognised brand would continue while the remaining acquisition was still ahead. For the people running COSRX, belonging to a larger group meant an extended period of cooperation, with both sides retaining a financial reason to care about what happened to the business.

Source: Amorepacific · Amended acquisition disclosure, April 2025

The Distribution Network Needed Repair

The product appeal survived a more difficult operational passage. In its February 2026 annual results, Amorepacific said COSRX had completed distribution-network restructuring and returned to revenue growth in the final quarter of 2025. The Peptide line contributed to that return. The work between acquisition and recovery therefore included changing how goods reached customers, as well as introducing something new for them to buy. That sequence is familiar to a shopper even when the organisational work is invisible. A brand must be available in the places people trust, in an assortment that makes sense, without losing the qualities that made it attractive. Amorepacific's account places channel repair beside product renewal. Both were needed to take the acquired business into its next stage.

The recovery also coincided with a wider change in Amorepacific's overseas operation. Greater China returned to profitability, while launches including AESTURA and HANYUL broadened the Americas portfolio. Overseas annual sales reached KRW 1.9091 trillion and operating profit KRW 209.9 billion, rising 15% and 102% respectively. COSRX was participating in an organisation changing several parts of its business at once.

Source: Amorepacific · FY2025 results and channel restructuring, 6 February 2026

Japan Brought COSRX Into About 2,900 Shops

By the third quarter of 2026, the next stage was visible on Japanese shelves. Amorepacific's 29 October update said COSRX had entered approximately 2,900 stores nationwide and more than doubled its Japanese revenue year on year. Its RX and PDRN lines were contributing across major markets, giving the brand products to put in front of customers beyond its earlier signature range.

The physical rollout adds another way to discover a digitally established brand. A customer can inspect the bottle, compare it with nearby products and buy it during an ordinary shopping trip. Online familiarity can help that encounter, while store availability makes a later purchase less dependent on finding the same seller again. The expansion changes the shopping journey as well as the distribution map.

Europe supplied another route. COSRX revenue in EMEA rose more than 30% in the quarter, with TikTok Shop UK revenue increasing more than 200%. The group was using both conventional retail access and a platform where demonstration and discovery can occur close to purchase. The repaired distribution network was supporting several kinds of customer encounter.

Source: Amorepacific · Q3 2026 business performance, 29 October 2026

A Broader Portfolio Is Following Different Customers

COSRX's progress now sits alongside brands answering other needs. AESTURA more than doubled its Americas revenue in the same quarter through channels including Sephora and Amazon, and entered Boots in Britain and Matas in the Nordic region. INNISFREE's Americas growth exceeded 50%, supported by Green Tea, sun care and PDRN products. This was a collection of different offers using an increasingly international organisation.

The pattern gives Kim's acquisition strategy a practical meaning. Bringing in COSRX expanded the group's knowledge of digital skincare demand; maintaining its products and repairing its routes to market required continuing work after control changed. Meanwhile, other brands supplied their own reasons for customers to approach the group.

Amorepacific reported third-quarter group sales of KRW 1.2073 trillion and operating profit of KRW 130.1 billion. Beauty subsidiaries undergoing channel optimisation still recorded weaker results, so the recovery remained uneven. The latest COSRX development is nevertheless concrete: after the distribution reset came renewed growth, new product lines and thousands of Japanese retail touchpoints. The acquisition has become an operating history, with the next chapter increasingly written where customers choose their skincare.

Source: Amorepacific · Q3 2026 business performance, 29 October 2026

DSML research · 8 October 2026 · Revised 31 October 2026